Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease

被引:5
|
作者
King, Annesha C. [1 ,2 ]
Wood, Tara E. [2 ]
Rodriguez, Efrain [2 ]
Parpura, Vladimir [3 ]
Gray, Michelle [2 ,3 ]
机构
[1] Univ Alabama Birmingham, Grad Biomed Sci Neurosci Theme, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA
基金
美国国家卫生研究院;
关键词
Huntington's disease; Full-length mutant huntingtin; Huntingtin; Astrocytes; Gliotransmission; BACHD; dnSNARE; MUTANT HUNTINGTIN; GLUTAMATE TRANSPORT; SECRETORY-CELLS; SEX-DIFFERENCES; IN-VIVO; ASTROCYTES; EXPRESSION; RELEASE; SYMPTOMS; R6/2;
D O I
10.1016/j.expneurol.2020.113358
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is a dominantly inherited neurodegenerative disease caused by a polyglutamine expansion in the widely expressed huntingtin protein. Multiple studies have indicated the importance of mutant huntingtin (mHTT) in astrocytes to HD pathogenesis. Astrocytes exhibit SNARE-dependent exocytosis and gliotransmission, which can be hampered by transgenic expression of dominant negative SNARE (dnSNARE) in these glial cells. We used BACHD mice and crossed them with the dnSNARE model to determine if pan-astrocytic SNARE-dependent exocytosis plays an important role in vivo in the progression of HD behavioral phenotypes. We assessed motor and neuropsychiatric behaviors in these mice. At 12 months of age there was a significant improvement in motor coordination (rotarod test) in BACHD/dnSNARE mice when compared to BACHD mice. Analyses of open field performance revealed significant worsening of center entry (at 9 and 12 months), but not distance traveled in BACHD/dnSNARE when compared to BACHD mice, and variable/inconclusive results on vertical plane entry. While no differences between BACHD and BACHD/dnSNARE mice at 12 months of age in the forced swim test were found, we did observe a significant decrease in performance of BACHD/dnSNARE mice in the light-dark box paradigm. Thus, reduction of astrocytic SNARE-dependent exocytosis has differential effects on the psychiatric-like and motor phenotypes observed in BACHD mice. These data suggest broadly targeting SNARE-dependent exocytosis in astrocytes throughout the brain as a means to modulate gliotransmission in HD may contribute to worsening of specific behavioral deficits and perhaps a brain-region specific approach would be required.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Modulation of SNARE-dependent exocytosis in astrocytes improves neuropathology in Huntington's disease
    King, Annesha C.
    Payne, Emily
    Stephens, Emily
    Fowler, Jahmel A.
    Wood, Tara E.
    Rodriguez, Efrain
    Gray, Michelle
    DISEASE MODELS & MECHANISMS, 2024, 17 (11)
  • [2] EFFECTS OF MITOQ ON BEHAVIOURAL AND BIOCHEMICAL PHENOTYPES OF A HUNTINGTON'S DISEASE MOUSE MODEL
    Pinho, Brigida R.
    Duarte, Ana I.
    Almeida, Liliana M.
    Canas, Paula M.
    Moreira, Paula I.
    Murphy, Mike P.
    Oliveira, Jorge M. A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A91 - A91
  • [3] Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington’s Disease
    Magali Cabanas
    Cristiana Pistono
    Laura Puygrenier
    Divyangana Rakesh
    Yannick Jeantet
    Maurice Garret
    Yoon H. Cho
    Neurotherapeutics, 2019, 16 : 784 - 796
  • [4] Neurophysiological and Behavioral Effects of Anti-Orexinergic Treatments in a Mouse Model of Huntington's Disease
    Cabanas, Magali
    Pistono, Cristiana
    Puygrenier, Laura
    Rakesh, Divyangana
    Jeantet, Yannick
    Garret, Maurice
    Cho, Yoon H.
    NEUROTHERAPEUTICS, 2019, 16 (03) : 784 - 796
  • [5] Early behavioral phenotypes in mouse models of Huntington's and Parkinson's diseases
    Chesselet, MF
    Hickey, MA
    Fleming, SM
    Fernagut, PO
    BASAL GANGLIA VIII, 2005, 56 : 349 - +
  • [6] Molecular and behavioral characterization or a knock-in mouse model or Huntington's disease
    Rising, A.
    Lewin, A. S.
    Denovan-Wright, E. M.
    Mandel, R. J.
    CELL TRANSPLANTATION, 2007, 16 (03) : 343 - 343
  • [7] Oleocanthal Ameliorates Metabolic and Behavioral Phenotypes in a Mouse Model of Alzheimer's Disease
    Yang, Euitaek
    Wang, Junwei
    Woodie, Lauren N.
    Greene, Michael W.
    Kaddoumi, Amal
    MOLECULES, 2023, 28 (14):
  • [8] Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington's disease
    Cuesta, Marc
    Aungier, Juliet
    Morton, A. Jennifer
    NEUROBIOLOGY OF DISEASE, 2014, 63 : 85 - 91
  • [9] Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease
    Ferrante, RJ
    Andreassen, OA
    Jenkins, BG
    Dedeoglu, A
    Kuemmerle, S
    Kubilus, JK
    Kaddurah-Daouk, R
    Hersch, SM
    Beal, MF
    JOURNAL OF NEUROSCIENCE, 2000, 20 (12): : 4389 - 4397
  • [10] A Behavioral, Histopatholgical, and Anatomical Characterization of the CAG140 Huntington's Disease Mouse Model
    Rising, A. C.
    Denovan-Wright, E.
    Mandel, R.
    CELL TRANSPLANTATION, 2010, 19 (03) : 359 - 359